Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Leiomyoma × elagolix × Clear all

Phase

Phase 3 4 Phase 4 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 1 Menorrhagia 1 Leiomyoma 1

Interventions

telapristone acetate 10 ulipristal 3 vilaprisan 2 Mifepristone 2 Leuprolide 2 ulipristal acetate 1 relugolix 1 pirfenidone 1 estradiol, norethindrone drug combination 1 epigallocatechin gallate 1 elagolix 1 asoprisnil 1 Tea 1 Sugars 1 Norethindrone Acetate 1 Morphine 1 Methadone 1 Lidocaine 1 Estradiol 1 Embolization, Therapeutic 1 Bupivacaine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01817530 2020-07-21

Safety and Efficacy in Premenopausal Women With Heavy Menstrual Bleeding (HMB) Associated With Uterine Fibroids (UF)

AbbVie

Phase 2 Completed

571 enrolled 32 charts

Leiomyoma, Menorrhagia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡